Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Ann Nucl Med ; 19(3): 243-6, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15981680

RESUMO

A 48-year-old male patient was admitted to our hospital with dyspnea accompanied by orthopnea. Chest x-rays showed a cardiothoracic ratio of 68% and pulmonary congestion. He was diagnosed with dilated cardiomyopathy. Beta-Blocker (carvedilol) therapy was initiated on Day 22 of the disease using a small initial dose. He was followed up based on BNP levels and MIBG scintigraphy. The H/M ratio and MIBG washout rate were 1.98 and 33.4%, respectively, on Day 20 and 2.15 and 28.1%, respectively, on Day 72. The patient was discharged on Day 72 when congestive heart failure improved. Relatively high BNP levels were observed for 1 month after starting treatment with a beta-blocker. Plasma BNP levels were still as high when his heart failure was improved. BNP is useful as a convenient indicator for the severity of cardiac diseases. MIBG scintigraphy may be used thereafter to evaluate the severity in greater detail and more precisely determine the prognosis.


Assuntos
3-Iodobenzilguanidina , Carbazóis/uso terapêutico , Cardiomiopatia Dilatada/diagnóstico , Cardiomiopatia Dilatada/tratamento farmacológico , Peptídeo Natriurético Encefálico/sangue , Propanolaminas/uso terapêutico , Antagonistas Adrenérgicos beta/uso terapêutico , Cardiomiopatia Dilatada/sangue , Carvedilol , Seguimentos , Humanos , Pessoa de Meia-Idade , Prognóstico , Compostos Radiofarmacêuticos , Índice de Gravidade de Doença , Tomografia Computadorizada de Emissão de Fóton Único/métodos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA